Haynes, RB. Improving patient adherence: state of the art, with special focus on medication taking for cardiovascular disorders. In Compliance in Health Care and Research (eds Burke, LE, Ockene, IS): 3–21. Futura, 2001.
Haynes, RB, Yao, X, Degani, A, Kripalani, S, Garg, A, McDonald, HP. Interventions for enhancing medication adherence. Cochrane Database Syst Rev
2005; 4: CD000011.
McLellan, AT, Lewis, DC, O'Brien, CP, Kleber, HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA
Wilson, JF, Smith, BL. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic samples. Ann Clin Biochem
1999; 36: 592–600.
Plasma methadone monitoring: an aid to dose assessment, monitoring compliance and exploration of drug interactions. In Methadone Matters (eds Tober, G, Strang, J): 67–78. Martin Dunitz, 2003.
Sankar, AP, Nevedal, DC, Neufeld, S, Luborsky, MR. What is a missed dose? Implications for construct validity and patient adherence. AIDS Care
2007; 19: 775–80.
Fountain, J, Strang, J, Gossop, M, Farrell, M, Griffiths, P.
Diversion of prescribed drugs by drug users in treatment; analysis of the UK market and new data from London. Addiction
2000; 95: 393–406.
Children poisoned with illegal drugs in Glasgow. BMJ
1999; 318: 1137.
Department of Health and the Devolved Administrations. Drug Misuse and Dependence–UK Guidelines on Clinical
Management. Department of Health, 2007.
Haskew, M, Wolff, K, Dunn, J, Bearn, J.
Patterns of adherence to oral methadone: implications for prescribers. J Subst Abuse Treat
2008; 35: 109–15.
Farrell, M, Hall, W.
Methadone and opioid-related deaths: changing prevalence over time. In Methadone Matters (eds Tober, G, Strang, J): 141–54. Martin Dunitz, 2003.
Best, D, Ridge, G.
‘Using on top’ and the problems it brings; additional drug use by methadone treatment patients. In Methadone Matters (eds Tober, G, Strang, J): 155–66. Martin Dunitz, 2003.
Gossop, M, Marsden, J, Stewart, D, Tracey, S.
Outcomes after methadone maintenance and methadone reduction treatments: two year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend
2001; 62: 255–64.
Fairley, CK, Permana, A, Read, TRH. Long term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med
2005; 6: 366–9.
Nachega, JB, Hislop, M, Dowdy, DW, Chaisson, RE, Regebsberg, L, Maartens, G.
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med
2007; 146: 564–73.